Sign In
Buy DNA
$7.89
-0.110 (-1.38%)
At Close: Jun 12, 2026
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Ginkgo Bioworks Holdings, Inc. (NYSE: DNA)
05:42pm, Tuesday, 23'rd Jul 2024
NEW YORK , July 23, 2024 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) on behalf of the company's shareholders. The investigati
7 Meme Mania Stocks: Which Are FOMO and Which Are Free Money?
06:45am, Tuesday, 23'rd Jul 2024
Meme stocks, fueled by social media hype, can soar or crash rapidly. While some see potential for explosive gains, others pose a high risk.
U.S. Defense Logistics Agency Exercises 1-Year Option Period in Applied DNA Counterfeit Mitigation Contract
10:00am, Thursday, 18'th Jul 2024
STONY BROOK, NY / ACCESSWIRE / July 18, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in PCR-based DNA technologies, today announced that the U.S. Defense Logistics Agency (D
AI Demand and New Deals Make Ginkgo Bioworks Stock a Speculative Buy
06:16am, Thursday, 18'th Jul 2024
Ginkgo Bioworks Holdings (NYSE: DNA ), which develops platforms for cell programming, has multiple, positive potential catalysts and a rather low valuation. Moreover, the shares should benefit from in
DNA Stock: Ginkgo Bioworks Announces New Collaboration
04:16pm, Tuesday, 16'th Jul 2024
Biotechnology specialist Ginkgo Bioworks (NYSE: DNA ) is seeing shares skyrocket today following an announcement of a potentially lucrative collaboration. Specifically, Ginkgo will partner with Syngen
Syngenta collaborates with Ginkgo Bioworks to enable faster launch of innovative biologicals
07:01am, Tuesday, 16'th Jul 2024
Syngenta will leverage Ginkgo's Ag Biologicals capabilities to optimize secondary metabolite production for a pioneering biological solution BASEL, Switzerland and BOSTON , July 16, 2024 /PRNewswire/
Down 81% in 2024, Is Ginkgo Bioworks Stock Still a Buy?
08:05am, Sunday, 14'th Jul 2024
Ginkgo Bioworks is scaling down its workforce and operating footprint. It's also aiming to restrict the scope of the services it offers.
Ginkgo Bioworks Holdings, Inc. (DNA) Sees a More Significant Dip Than Broader Market: Some Facts to Know
07:22pm, Thursday, 11'th Jul 2024
The latest trading day saw Ginkgo Bioworks Holdings, Inc. (DNA) settling at $0.32, representing a -1.51% change from its previous close.
3 Stocks to Avoid Like the Plague in 2024
06:00am, Thursday, 11'th Jul 2024
It's crucial to steer clear of potential pitfalls that could sink your portfolio. With the S&P 500 and Nasdaq posting impressive year-to-date gains, it's tempting to get caught up in the bullish fervo
3 High-Risk, Sky-High Reward Stocks to Buy for Under $1
04:08pm, Wednesday, 10'th Jul 2024
High-risk penny stocks are known for their volatility. They often feature low trading volumes, minimal prices and unstable financial and fundamental standings.
Stay Away: Why Ginkgo Bioworks Stock Is Not for the Faint-Hearted
06:35am, Wednesday, 10'th Jul 2024
There's definitely a science to picking beaten-down gems in the stock market. If you get it wrong, you could lose a lot of money.
3 Biotech Stocks to Sell in July Before They Crash & Burn
07:30am, Friday, 05'th Jul 2024
The biotech segment is a relatively new sector that combines the fields of biology and technology. It integrates natural sciences from biology and engineering aspects from technology to develop produc
3 Biotech Stocks Turning DNA Dreams Into Dollars
06:55am, Friday, 05'th Jul 2024
When discussing biotechnology, many focus on medication based on biochemical compounds and their downstream effects. Yet several branches of medical genetics and therapeutics have begun to find novel
3 Top-Rated Gene Editing Stocks Actually Making Money
03:11pm, Wednesday, 03'rd Jul 2024
Gene editing utilizes enzymes that cut part of the DNA strand, allowing the insertion of replacement DNA. Several approaches to gene editing have been developed, the most well-known of which is CRISPR
Rags to Riches: 3 Biotech Stocks That Could Make Early Investors Rich
03:38pm, Thursday, 27'th Jun 2024
In 2024, the iShares Biotechnology ETF (NASDAQ: IBB ) is up just over 1.5%. If you're looking for steady, dividend-paying stocks, you can find a number of biotech stocks to buy from the holdings in t
